Back to catalog
GHK-Cu Astral research vial

GHK-Cu

Also known as Copper Tripeptide-1 · Gly-His-Lys Copper

Copper tripeptide — A copper-binding tripeptide (Gly-His-Lys) complexed with Cu²⁺. Investigated in fibroblast, dermal-matrix and collagen research models.

Latest released COA: 99.88%Lyophilized powder

Available vial sizes

  • 50 mg$27.99In stock
  • 100 mg$47.99In stock

From $27.99In stock

View purchase options

Specifications

CAS number89030-95-5
Molecular formulaC14H22CuN6O4
Molecular weight403.93 g/mol
FormLyophilized powder
Research use only. Not for human or veterinary use, consumption, diagnosis, treatment, or therapeutic purposes.

Documentation

Certificates of Analysis

Batch-specific, third-party lab certificates. Each COA is published here once its lot has been tested — preview the results, then open the full PDF.

Current released record

AST-CU100-001

Dosage
100 mg
Purity
99.6%
Laboratory
ILS Laboratories
Analyzed
2026-08-10
Open source PDF

Current released record

AST-CU-001

Dosage
50 mg
Purity
99.88%
Laboratory
ILS Laboratories
Analyzed
2026-08-10
Open source PDF

View the compound COA record →

Related

More to explore

View all

Research context

GHK-Cu research, identity and references

Also known as Copper Tripeptide-1, Gly-His-Lys Copper

What is GHK-Cu studied for?

GHK is a naturally occurring tripeptide that binds copper. The cited literature discusses cellular signaling, skin-model, and tissue-remodeling research; it does not verify the composition of a commercial vial or support human-use directions.

CAS number89030-95-5
Molecular formulaC14H22CuN6O4
Molecular weight403.93 g/mol
SequenceGly-His-Lys : Cu²⁺

Animal study

  1. Animal study

    Tripeptide-copper complex GHK-Cu (II) transiently improved healing outcome in a rat model of ACL reconstruction.

    Fu SC, Cheuk YC, Chiu WY, et al. Journal of Orthopaedic Research (2015).

    A rat model with an explicitly transient result. Reported here as model evidence and its limit, not as an outcome claim.

    PMID 25731775 · DOI 10.1002/jor.22831

Cell-culture study

  1. Cell-culture study

    Stem cell recovering effect of copper-free GHK in skin.

    Choi HR, Kang YA, Ryoo SJ, et al. Journal of Peptide Science (2012).

    Examines copper-free GHK in a skin cell model and should not be generalized to GHK-Cu product performance.

    PMID 23019153 · DOI 10.1002/psc.2455

Analytical-method review

  1. Analytical-method review

    Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes?

    Ogorek K, Nowak K, Wadych E, et al. Molecules (2025).

    Concerns how permeation of this tripeptide is measured. Included for analytical context, which is the kind of evidence a COA speaks to.

    PMID 39795193 · DOI 10.3390/molecules30010136

Literature review

  1. Literature review

    GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration.

    Pickart L, Vasquez-Soltero JM, Margolina A. BioMed Research International (2015).

    Summarizes cellular pathways associated with GHK in skin-related research models.

    PMID 26236730 · DOI 10.1155/2015/648108

Scientific review

  1. Scientific review

    The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health.

    Pickart L, Vasquez-Soltero JM, Margolina A Oxidative Medicine and Cellular Longevity (2012).

    Reviews proposed signaling roles for the copper-binding tripeptide. A hypothesis-level review, not a demonstration of effect in people.

    PMID 22666519 · DOI 10.1155/2012/324832

Editorially curated and source-verified; not independently peer-reviewed by Astral. Last source check: 2026-08-04. How sources are selected.

Check released lot evidence →